Skip to main content
O

OncoGenomX

PredictionStar is a point-of-care decision support platform that utilizes patented algorithms to analyze tumor-specific genomic, biological, and clinical data for breast cancer patients. This technology addresses the high risk of suboptimal treatment choices by providing evidence-based therapy recommendations, ultimately improving patient outcomes and reducing unnecessary healthcare costs.

Allschwil, SwitzerlandFounded 20202300+ followers
Updated 20 months ago

Funding

$1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

GH
Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Features

  • PredictionStar is a point-of-care decision support platform that utilizes patented algorithms to analyze tumor-specific genomic, biological, and clinical data for breast cancer patients. This technology addresses the high risk of suboptimal treatment choices by providing evidence-based therapy recommendations, ultimately improving patient outcomes and reducing unnecessary healthcare costs.
This profile is AI-generated and may contain inaccuracies.